Get latest articles and stories on Health at LatestLY. A new study evaluates the effects of menopausal symptoms on the intensity of pain caused by temporomandibular disorder during menopause. Health News | Pain Caused by TMJ Disorders May Be Aggravated by Late Menopause Transition.
The Coalition for Epidemic Preparedness Innovations (CEPI) on Tuesday announced the latest award under its USD 200 m programme to advance the development of vaccines that provide broad protection against SARS-Cov-2 variants and other beta coronaviruses.
Get latest articles and stories on Health at LatestLY. An American study that enrolled a highly diverse group of pregnant women over 12 years found rising exposure to chemicals from plastics and pesticides that may be harmful to development. Health News | Research on Pregnant Women Discovers Increasing Chemical Exposure.
Get latest articles and stories on World at LatestLY. Uzbekistan's Deputy Minister of Foreign Affairs Furkat Sidikov on Tuesday said that his country can be a gateway for Indian businessmen to get access to the Eurasian market. World News | Uzbek Minister Expresses Interest to Access Chabahar Port, Says Uzbekistan Can Be India's Gateway to Eurasia.
Close
The Valneva COVID-19 vaccine is said to be reliant in terms of its reliance against the virus. This shot from the French company, Valneva, has yet to reach completion of his clinical trials.
However, according to Rappler, the vaccine has caught the eye of governments, specifically in Australia, Europe, and the United Kingdom.
One of the main selling points of this vaccine is its seeming ability to mount a more common immune reaction against SARS-CoV-2, the virus that causes COVID-19, instead of depending on the spike protein to do this.
Meaning, the vaccine is more possible to be effective protection against the variant types already seen developing and may appear in the future. Some reports, including the one from The Coronavirus Pandemic, describe the Valneva COVID-19 vaccine as variant proof.